Recombinant human soluble CEACAM-1-Fc (produced in HEK293 cells)
Cross-Reactivity (Details)
Anti-human CEACAM-1 (B3) interacts solely with human CEACAM-1 and shows no cross-reactivity with other CEACAMs expressed in human or other species!
Characteristics
Chromosomal location: 19q13.2 Monoclonal antibodies were produced with the help of BALB/c mice using recombinant human soluble CEACAM-1-Fc (produced in HEK293 cells) as the immunizing antigen.
Purification
The antibody (clone #B3) was purified from cell culture supernatant by Protein G chromatography.
Immunogen
Recombinant human soluble CEACAM-1-Fc (produced in HEK293 cells)
ELISA: Use at 10 μg/mL, WB: Use at 5 μg/mL, Immunohistochemistry: Use at 10 μg/mL, FACS analysis: Use at 10 μg/mL.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
Buffer
PBS
Handling Advice
Centrifuge vial prior to opening.
Storage
4 °C,-20 °C
Storage Comment
The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
CEACAM1, BGP, BGP1, BGPI, CD66a,Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM-1), also known as CD66a and BGP-I, is a 115 kDa type I transmembrane glycoprotein that belongs to the membrane-bound CEA subfamily of the CEA superfamily. On the surface of cells, it forms noncovalent homo- and heterodimers. The extracellular region contains three C2-type Ig-like domains and one N-terminal V-type Ig-like domain. Multiple splice variants involving regions C-terminal to the second C2-type domain (aa 320 and beyond) exist.